Global Antisense Oligonucleotide (ASO) Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size 2017-2028

2.1.2 Antisense Oligonucleotide (ASO) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Antisense Oligonucleotide (ASO) Therapeutics Segment by Type

2.2.1 Pulmonary Delivery

2.2.2 Intravenous Injections

2.2.3 Intradermal Injections

2.2.4 Intraperitoneal Injections

2.2.5 Topical Delivery

2.2.6 Others

2.3 Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type

2.3.1 Antisense Oligonucleotide (ASO) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Antisense Oligonucleotide (ASO) Therapeutics Segment by Application

2.4.1 Genetic Disorders

2.4.2 Neurological Disorders

2.4.3 Oncological Disorders

2.4.4 Metabolic Disorders

2.4.5 Ophthalmic Disorders

2.4.6 Others

2.5 Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application

2.5.1 Antisense Oligonucleotide (ASO) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application (2017-2022)

3 Antisense Oligonucleotide (ASO) Therapeutics Market Size by Player

3.1 Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Players

3.1.1 Global Antisense Oligonucleotide (ASO) Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Antisense Oligonucleotide (ASO) Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Antisense Oligonucleotide (ASO) Therapeutics by Regions

4.1 Antisense Oligonucleotide (ASO) Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth (2017-2022)

4.3 APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth (2017-2022)

4.4 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2017-2022)

5.2 Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022)

5.3 Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2017-2022)

6.2 APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022)

6.3 APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Antisense Oligonucleotide (ASO) Therapeutics by Country (2017-2022)

7.2 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022)

7.3 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.1 Global Antisense Oligonucleotide (ASO) Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Antisense Oligonucleotide (ASO) Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Antisense Oligonucleotide (ASO) Therapeutics Forecast

10.1.3 APAC Antisense Oligonucleotide (ASO) Therapeutics Forecast

10.1.4 Europe Antisense Oligonucleotide (ASO) Therapeutics Forecast

10.1.5 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Forecast

10.2 Americas Antisense Oligonucleotide (ASO) Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.2.2 Canada Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.2.3 Mexico Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.2.4 Brazil Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.3 APAC Antisense Oligonucleotide (ASO) Therapeutics Forecast by Region (2023-2028)

10.3.1 China Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.3.2 Japan Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.3.3 Korea Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.3.4 Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.3.5 India Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.3.6 Australia Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.4 Europe Antisense Oligonucleotide (ASO) Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.4.2 France Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.4.3 UK Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.4.4 Italy Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.4.5 Russia Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.5 Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.5.2 South Africa Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.5.3 Israel Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.5.4 Turkey Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.5.5 GCC Countries Antisense Oligonucleotide (ASO) Therapeutics Market Forecast

10.6 Global Antisense Oligonucleotide (ASO) Therapeutics Forecast by Type (2023-2028)

10.7 Global Antisense Oligonucleotide (ASO) Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Ionis Pharmaceuticals, Inc

11.1.1 Ionis Pharmaceuticals, Inc Company Information

11.1.2 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.1.3 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Ionis Pharmaceuticals, Inc Main Business Overview

11.1.5 Ionis Pharmaceuticals, Inc Latest Developments

11.2 Sarpeta Therapeutics Inc.

11.2.1 Sarpeta Therapeutics Inc. Company Information

11.2.2 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.2.3 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sarpeta Therapeutics Inc. Main Business Overview

11.2.5 Sarpeta Therapeutics Inc. Latest Developments

11.3 Biogen Inc

11.3.1 Biogen Inc Company Information

11.3.2 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.3.3 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Biogen Inc Main Business Overview

11.3.5 Biogen Inc Latest Developments

11.4 Alnylam Pharmaceuticals, Inc

11.4.1 Alnylam Pharmaceuticals, Inc Company Information

11.4.2 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.4.3 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Alnylam Pharmaceuticals, Inc Main Business Overview

11.4.5 Alnylam Pharmaceuticals, Inc Latest Developments

11.5 Antisense Therapeutics Limited

11.5.1 Antisense Therapeutics Limited Company Information

11.5.2 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.5.3 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Antisense Therapeutics Limited Main Business Overview

11.5.5 Antisense Therapeutics Limited Latest Developments

11.6 Arrowhead Pharmaceuticals Inc.

11.6.1 Arrowhead Pharmaceuticals Inc. Company Information

11.6.2 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.6.3 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Arrowhead Pharmaceuticals Inc. Main Business Overview

11.6.5 Arrowhead Pharmaceuticals Inc. Latest Developments

11.7 Enzon Pharmaceuticals, Inc.

11.7.1 Enzon Pharmaceuticals, Inc. Company Information

11.7.2 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.7.3 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Enzon Pharmaceuticals, Inc. Main Business Overview

11.7.5 Enzon Pharmaceuticals, Inc. Latest Developments

11.8 Bio-Path Holdings, Inc.

11.8.1 Bio-Path Holdings, Inc. Company Information

11.8.2 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.8.3 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Bio-Path Holdings, Inc. Main Business Overview

11.8.5 Bio-Path Holdings, Inc. Latest Developments

11.9 GlaxoSmithKline PLC

11.9.1 GlaxoSmithKline PLC Company Information

11.9.2 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.9.3 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 GlaxoSmithKline PLC Main Business Overview

11.9.5 GlaxoSmithKline PLC Latest Developments

11.10 Geron Corporation (Geron)

11.10.1 Geron Corporation (Geron) Company Information

11.10.2 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Offered

11.10.3 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Geron Corporation (Geron) Main Business Overview

11.10.5 Geron Corporation (Geron) Latest Developments

12 Research Findings and Conclusion

Table 1. Antisense Oligonucleotide (ASO) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Pulmonary Delivery

Table 3. Major Players of Intravenous Injections

Table 4. Major Players of Intradermal Injections

Table 5. Major Players of Intraperitoneal Injections

Table 6. Major Players of Topical Delivery

Table 7. Major Players of Others

Table 8. Antisense Oligonucleotide (ASO) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2017-2022)

Table 11. Antisense Oligonucleotide (ASO) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application (2017-2022)

Table 14. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Player (2020-2022)

Table 16. Antisense Oligonucleotide (ASO) Therapeutics Key Players Head office and Products Offered

Table 17. Antisense Oligonucleotide (ASO) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Regions (2017-2022)

Table 22. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Country (2017-2022)

Table 24. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2017-2022)

Table 26. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application (2017-2022)

Table 28. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Region (2017-2022)

Table 30. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2017-2022)

Table 32. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application (2017-2022)

Table 34. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Country (2017-2022)

Table 36. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2017-2022)

Table 38. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Antisense Oligonucleotide (ASO) Therapeutics

Table 47. Key Market Challenges & Risks of Antisense Oligonucleotide (ASO) Therapeutics

Table 48. Key Industry Trends of Antisense Oligonucleotide (ASO) Therapeutics

Table 49. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 55. Ionis Pharmaceuticals, Inc Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 56. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 57. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. Ionis Pharmaceuticals, Inc Main Business

Table 59. Ionis Pharmaceuticals, Inc Latest Developments

Table 60. Sarpeta Therapeutics Inc. Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 61. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 62. Sarpeta Therapeutics Inc. Main Business

Table 63. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. Sarpeta Therapeutics Inc. Latest Developments

Table 65. Biogen Inc Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 66. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 67. Biogen Inc Main Business

Table 68. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Biogen Inc Latest Developments

Table 70. Alnylam Pharmaceuticals, Inc Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 71. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 72. Alnylam Pharmaceuticals, Inc Main Business

Table 73. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Alnylam Pharmaceuticals, Inc Latest Developments

Table 75. Antisense Therapeutics Limited Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 76. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 77. Antisense Therapeutics Limited Main Business

Table 78. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Antisense Therapeutics Limited Latest Developments

Table 80. Arrowhead Pharmaceuticals Inc. Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 81. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 82. Arrowhead Pharmaceuticals Inc. Main Business

Table 83. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Arrowhead Pharmaceuticals Inc. Latest Developments

Table 85. Enzon Pharmaceuticals, Inc. Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 86. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 87. Enzon Pharmaceuticals, Inc. Main Business

Table 88. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Enzon Pharmaceuticals, Inc. Latest Developments

Table 90. Bio-Path Holdings, Inc. Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 91. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 92. Bio-Path Holdings, Inc. Main Business

Table 93. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Bio-Path Holdings, Inc. Latest Developments

Table 95. GlaxoSmithKline PLC Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 96. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 97. GlaxoSmithKline PLC Main Business

Table 98. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. GlaxoSmithKline PLC Latest Developments

Table 100. Geron Corporation (Geron) Details, Company Type, Antisense Oligonucleotide (ASO) Therapeutics Area Served and Its Competitors

Table 101. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Offered

Table 102. Geron Corporation (Geron) Main Business

Table 103. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Geron Corporation (Geron) Latest Developments

List of Figures

Figure 1. Antisense Oligonucleotide (ASO) Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type in 2021

Figure 7. Antisense Oligonucleotide (ASO) Therapeutics in Genetic Disorders

Figure 8. Global Antisense Oligonucleotide (ASO) Therapeutics Market: Genetic Disorders (2017-2022) & ($ Millions)

Figure 9. Antisense Oligonucleotide (ASO) Therapeutics in Neurological Disorders

Figure 10. Global Antisense Oligonucleotide (ASO) Therapeutics Market: Neurological Disorders (2017-2022) & ($ Millions)

Figure 11. Antisense Oligonucleotide (ASO) Therapeutics in Oncological Disorders

Figure 12. Global Antisense Oligonucleotide (ASO) Therapeutics Market: Oncological Disorders (2017-2022) & ($ Millions)

Figure 13. Antisense Oligonucleotide (ASO) Therapeutics in Metabolic Disorders

Figure 14. Global Antisense Oligonucleotide (ASO) Therapeutics Market: Metabolic Disorders (2017-2022) & ($ Millions)

Figure 15. Antisense Oligonucleotide (ASO) Therapeutics in Ophthalmic Disorders

Figure 16. Global Antisense Oligonucleotide (ASO) Therapeutics Market: Ophthalmic Disorders (2017-2022) & ($ Millions)

Figure 17. Antisense Oligonucleotide (ASO) Therapeutics in Others

Figure 18. Global Antisense Oligonucleotide (ASO) Therapeutics Market: Others (2017-2022) & ($ Millions)

Figure 19. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application in 2021

Figure 20. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Player in 2021

Figure 21. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 22. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 23. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 24. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 26. Americas Antisense Oligonucleotide (ASO) Therapeutics Value Market Share by Country in 2021

Figure 27. Americas Antisense Oligonucleotide (ASO) Therapeutics Consumption Market Share by Type in 2021

Figure 28. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application in 2021

Figure 29. United States Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Region in 2021

Figure 34. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application in 2021

Figure 35. China Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. India Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Country in 2021

Figure 42. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type in 2021

Figure 43. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application in 2021

Figure 44. Germany Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. France Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Application in 2021

Figure 52. Egypt Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country Antisense Oligonucleotide (ASO) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. APAC Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. United States Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Canada Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Mexico Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Brazil Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. China Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Japan Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Korea Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. India Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Australia Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Germany Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. France Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. UK Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Italy Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. Russia Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 76. Spain Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 77. Egypt Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 78. South Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 79. Israel Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 80. Turkey Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries Antisense Oligonucleotide (ASO) Therapeutics Market Size 2023-2028 ($ Millions)